Latest T-cell lymphoma Stories
RnRMarketResearch.com adds “Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015” to its store.
RnRMarketResearch.com adds "T-Cell Leukemia and Peripheral T-Cell Lymphomas - Pipeline Review, H1 2015" to its store.
RnRMarketResearch.com adds "Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2014" to its store.
ResearchMoz.us includes new market research report "Peripheral T-Cell Lymphomas PTCL Clinical Trials Review, H1, 2014" to its huge collection of research reports.
Researchers say a drug approved for the treatment of relapsed T-cell Non-Hodgkin’s Lymphoma may help people with indolent B-cell varieties, too. Raleigh, NC
Australian researchers say the combination of a psychiatry drug with a photosensitizer may work “synergistically” in patients with a certain kind of Non-Hodgkin’s Lymphoma. Raleigh,
NK/T-cell lymphoma is a very aggressive form of cancer, and currently has no effective treatment along with having a poor prognosis. This subtype of lymphoma is pretty rare in the United States, but is responsible for a large number of deaths in Asia, particularly China and Korea.
WHITE PLAINS, N.Y., July 11, 2011 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) is taking an aggressive and proactive approach to tackling the challenge of improving outcomes for cancer patients with particularly urgent needs.
- The parings of haberdine; also, any kind of fragments.